Author Guidelines
Author Guidelines
Authors are invited to make a submission to the Journal of Innovation in Computer Science and Pharma-Bio Research. All submissions are first assessed by an editor to determine whether they meet the aims and scope of the journal. Submissions considered a good fit are sent for double-blind peer review before a decision is made.
Before making a submission, authors are responsible for obtaining permission to publish any material included with the submission, such as photos, documents, datasets, and software code. All authors identified on the submission must consent to be identified as an author. Where appropriate, research must be approved by an ethics committee in accordance with the legal requirements of the study’s country.
An editor may desk reject a submission that does not meet minimum standards of quality. The title should be concise, and the abstract should be able to stand on its own. Please review the guidance below and complete the Submission Preparation Checklist before submitting.
1. Manuscript Types
The journal considers the following types of submissions:
Original Research Articles
Reports of original research findings with clear methodology and analysis.
Review Articles
Systematic or critical reviews of existing literature relevant to computer science, pharmaceutical sciences, and biological research.
Short Communications
Brief reports of novel methods, preliminary results, or technical advancements.
Case Studies / Applied Research Reports
Practical implementations or real-world applications of computational methods in pharmaceutical and biological domains, and related fields.
Conceptual or Methodological Papers
Papers proposing frameworks, models, algorithms, or methodological advancements.
2. Manuscript Preparation and Formatting
Manuscripts should be prepared in clear and concise academic English.
General structure:
Title
Abstract (150–250 words)
Keywords (3–6)
Main text
References
Tables and figures (where applicable)
Formatting requirements:
Standard word processing format (e.g., DOC/DOCX)
Legible font and spacing
Pages and sections clearly numbered
Anonymization for double-blind review: The manuscript file must not contain author names, affiliations, or acknowledgments. Remove identifying information from the document properties as well. Author details should be provided separately during submission.
Detailed formatting templates may be provided separately.
3. Referencing Style
Authors must ensure that all sources are accurately cited and listed in the reference section.
The journal follows a standard academic referencing style (e.g., APA style)
References must be complete and consistent
All in-text citations must appear in the reference list and vice versa
Authors are responsible for the accuracy of all citations.
4. Ethical Approval and Research Integrity
For research involving human participants, animals, clinical data, or sensitive data, authors must:
Obtain appropriate ethical approval from a recognized institutional review board or ethics committee
Clearly state the approval details in the manuscript
Confirm that informed consent was obtained where applicable
Ensure privacy and appropriate de-identification of personal, patient, or health-related data
Manuscripts that do not meet ethical standards may be rejected.
5. AI-Generated Content Disclosure
Authors must disclose the use of artificial intelligence tools (e.g., for language editing, data analysis, code generation, or image generation) in the preparation of the manuscript.
AI tools must not be listed as authors
Authors remain fully responsible for the accuracy, originality, and integrity of the content
Any use of AI must comply with ethical research and publication standards
Failure to disclose significant AI assistance may be treated as a breach of publication ethics.
6. Data and Code Availability Statements
Authors are encouraged to include a Data Availability Statement (and a Code Availability Statement, where applicable) indicating:
Whether data or code supporting the findings are available
Where they can be accessed (repository, supplementary files, or upon reasonable request)
Any restrictions on access, if applicable (for example, patient privacy or proprietary constraints)
Transparency in data and code sharing supports reproducibility and research integrity.
7. Originality and Plagiarism
Submitted manuscripts must be original and not under consideration elsewhere. All submissions may be screened for plagiarism in accordance with the journal’s Plagiarism Policy.
8. Submission Confirmation
By submitting a manuscript, authors confirm that:
The work is original and unpublished
All authors have approved the submission
The manuscript complies with the journal’s ethical and editorial policies
Submission Preparation Checklist
All submissions must meet the following requirements. Submissions that do not adhere to these requirements may be returned to authors.
This submission meets the requirements outlined in the Author Guidelines.
This submission is original, has not been previously published, and is not under consideration by another journal.
The manuscript is in DOC/DOCX format and includes an abstract (150–250 words) and 3–6 keywords.
The manuscript has been anonymized for double-blind review: author names, affiliations, and acknowledgments have been removed from the manuscript file and document properties, and are provided separately.
All references have been checked for accuracy and completeness, and follow the journal’s referencing style.
All tables and figures have been numbered and labeled.
Permission has been obtained to publish all photos, datasets, software code, and other material provided with this submission.
For research involving human participants, animals, or clinical data, ethical approval and informed consent details are stated in the manuscript.
Any use of AI tools in preparing the manuscript has been disclosed.
A Data Availability Statement (and Code Availability Statement, where applicable) is included.
Conflicts of interest and funding sources have been declared.
Privacy Statement
The Journal of Innovation in Computer Science and Pharma-Bio Research respects the privacy of its authors, reviewers, editors, readers, and website visitors. This Privacy Statement summarizes our commitment to protecting personal information. For full details, please refer to our Privacy Policy.
Use of Personal Information
Names, email addresses, affiliations, and other personal details submitted through this journal website are used exclusively for the stated purposes of the journal, such as processing manuscripts, managing peer review, and communicating with authors, reviewers, and readers.
This information will not be made available for any other purpose or to any other party, except where necessary for manuscript processing, indexing, archiving, or as required by law.
Confidentiality of Submissions
Manuscripts, review reports, and editorial correspondence are treated as confidential. They are shared only with the individuals involved in the editorial and peer-review process.
Website Usage Data
The journal website may collect limited technical information, such as IP address, browser type, and usage patterns, for analytics and to improve website functionality. This data is not used to personally identify visitors for commercial purposes.
Data Security
The journal takes reasonable technical and organizational measures to protect personal data from unauthorized access, loss, or disclosure.
No Commercial Use
Personal data collected by the journal is not sold, rented, or shared with third parties for marketing or commercial purposes.
Your Rights
Users may request access to, correction of, or deletion of their personal data, subject to legal and archival requirements. Requests should be sent to the official journal contact email: editor@jicspbr.org
Updates to This Statement
This Privacy Statement may be updated from time to time. Any changes will be posted on the journal website.
